LeMaitre (NASDAQ:LMAT) Surprises With Q4 CY2025 Sales, Stock Soars [Yahoo! Finance]
LeMaitre Vascular, Inc. (LMAT)
Last lemaitre vascular, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
lemaitre.gcs-web.com/investor-relations
Company Research
Source: Yahoo! Finance
Guidance for next quarter's revenue was better than expected at $66.6 million at the midpoint, 0.7% above analysts' estimates. Its GAAP profit of $0.68 per share was 2.5% above analysts' consensus estimates. Is now the time to buy LeMaitre? Find out in our full research report LeMaitre (LMAT) Q4 CY2025 Highlights: Revenue: $64.45 million vs analyst estimates of $62.93 million (15.7% year-on-year growth, 2.4% beat) EPS (GAAP): $0.68 vs analyst estimates of $0.66 (2.5% beat) Adjusted EBITDA: $20.86 million vs analyst estimates of $20.54 million (32.4% margin, 1.6% beat) Revenue Guidance for Q1 CY2026 is $66.6 million at the midpoint, roughly in line with what analysts were expecting EPS (GAAP) guidance for the upcoming financial year 2026 is $2.91 at the midpoint, beating analyst estimates by 12.6% Operating Margin: 29.2%, up from 23.1% in the same quarter last year Organic Revenue rose 15% year on year (beat) Market Capitalization: $2.06 billion Chairman/CEO Georg
Show less
Read more
Impact Snapshot
Event Time:
LMAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LMAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LMAT alerts
High impacting LeMaitre Vascular, Inc. news events
Weekly update
A roundup of the hottest topics
LMAT
News
- 3 Healthcare Stocks We're Skeptical Of [Yahoo! Finance]Yahoo! Finance
- LeMaitre Vascular (LMAT) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "hold (c+)" to "buy (b-)".MarketBeat
- 2 Profitable Stocks with Exciting Potential and 1 We Turn Down [Yahoo! Finance]Yahoo! Finance
- LeMaitre Vascular (LMAT)'s Technical Outlook is Bright After Key Golden Cross [Yahoo! Finance]Yahoo! Finance
- LeMaitre Vascular (LMAT) Is Up 16.4% After Dividend Hike And Buyback Plan – Has The Bull Case Changed? [Yahoo! Finance]Yahoo! Finance
LMAT
Earnings
- 2/25/26 - Beat
LMAT
Sec Filings
- 3/13/26 - Form 4
- 3/13/26 - Form 4
- 3/12/26 - Form 4
- LMAT's page on the SEC website